Ascend Wellness Holdings reported mixed third-quarter 2026 results, with net revenue climbing to $130.02 million from $124.73 million in the prior year. Despite an operating profit of $4.5 million, the company's net loss widened to $27.95 million as interest expenses surged to $21.98 million. The firm's stockholders' deficit deepened to $112.41 million, while cash and cash equivalents declined to $63.63 million as of September 30, 2026.
Neutral
🤖 50%
Q3 2026 results are mixed: net revenue rose to $130,019 thousand from $124,734 thousand a year ago and operating profit swung to $4,500 thousand from a $(1,325) thousand loss, but the net loss widened to $(27,951) thousand from $(25,825) thousand as interest expense nearly doubled to $21,977 thousand. Adjusted EBITDA was flat at $31,139 thousand versus $31,094 thousand, and the stockholders' deficit deepened to $(112,408) thousand from $(46,617) thousand at year-end 2025 while cash fell to $63,625 thousand. Improving operations and margin offset by rising debt costs leave no clear directional
Catalysts
- • Q3 2026 revenue of $130.0 million, up from $124.7 million in Q3 2025
- • Operating profit of $4.5 million versus a $(1.3) million loss a year earlier
Risk Factors
- • Net loss widened to $(27.95) million from $(25.8) million with interest expense up to $22.0 million from $12.6 million
- • Stockholders' deficit grew to $(112.4) million from $(46.6) million at December 31, 2025